Form 4 for ALKS Alkermes plc.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-11 · accession 0001127602-24-027044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-12 | 2024-11-11 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $20.03 | +43.1K | 142.3K | +43% | +$862.5K |
| D | 2024-11-12 | 2024-11-11 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | S - Sale+OE | $30.08 | -59.0K | 83.3K | -41% | -$1.77M |
| D | 2024-11-12 | 2024-11-11 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | $0.00 | -43.1K | 129.2K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-11-11 | M | A | 43,058 | $20.03 | 142,296 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-11-11 | S | D | 58,996 | $30.08 | 83,300 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.20. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2024-11-11 | M | D | 43,058 | $0.00 | 129,174 | D | $20.03 · — to 2030-02-20 | 43,058 Ordinary Shares | (F4) These options are fully vested in accordance with their terms. |